Ellington Management Group’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-15,300
Closed -$169K 621
2017
Q2
$169K Buy
+15,300
New +$169K 0.02% 552
2016
Q4
Sell
-14,800
Closed -$184K 534
2016
Q3
$184K Buy
+14,800
New +$184K 0.05% 558
2015
Q1
Sell
-21,900
Closed -$375K 668
2014
Q4
$375K Buy
+21,900
New +$375K 0.12% 271